Increase in DNA Damage by MYCN Knockdown Through Regulating Nucleosome Organization and Chromatin State in Neuroblastoma

Hu, Xinjie and Zheng, Weisheng and Zhu, Qianshu and Gu, Liang and Du, Yanhua and Han, Zhe and Zhang, Xiaobai and Carter, Daniel R. and Cheung, Belamy B. and Qiu, Andong and Jiang, Cizhong (2019) Increase in DNA Damage by MYCN Knockdown Through Regulating Nucleosome Organization and Chromatin State in Neuroblastoma. Frontiers in Genetics, 10. ISSN 1664-8021

[thumbnail of pubmed-zip/versions/1/package-entries/fgene-10-00684.pdf] Text
pubmed-zip/versions/1/package-entries/fgene-10-00684.pdf - Published Version

Download (3MB)

Abstract

As a transcription factor, MYCN regulates myriad target genes including the histone chaperone FACT. Moreover, FACT and MYCN expression form a forward feedback loop in neuroblastoma. It is unclear whether MYCN is involved in chromatin remodeling in neuroblastoma through regulation of its target genes. We showed here that MYCN knockdown resulted in loss of the nucleosome-free regions through nucleosome assembly in the promoters of genes functionally enriched for DNA repair. The active mark H3K9ac was removed or replaced by the repressive mark H3K27me3 in the promoters of double-strand break repair-related genes upon MYCN knockdown. Such chromatin state alterations occurred only in MYCN-bound promoters. Consistently, MYCN knockdown resulted in a marked increase in DNA damage in the treatment with hydroxyurea. In contrast, nucleosome reorganization and histone modification changes in the enhancers largely included target genes with tumorigenesis-related functions such as cell proliferation, cell migration, and cell–cell adhesion. The chromatin state significantly changed in both MYCN-bound and MYCN-unbound enhancers upon MYCN knockdown. Furthermore, MYCN knockdown independently regulated chromatin remodeling in the promoters and the enhancers. These findings reveal the novel epigenetic regulatory role of MYCN in chromatin remodeling and provide an alternative potential epigenetic strategy for MYCN-driven neuroblastoma treatment.

Item Type: Article
Subjects: OA STM Library > Medical Science
Depositing User: Unnamed user with email support@oastmlibrary.com
Date Deposited: 17 Feb 2023 10:49
Last Modified: 25 May 2024 09:07
URI: http://geographical.openscholararchive.com/id/eprint/221

Actions (login required)

View Item
View Item